{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:07:07Z","timestamp":1793416027655,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.vaccine.2011.12.134","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T09:04:06Z","timestamp":1326186246000},"page":"1445-1452","source":"Crossref","is-referenced-by-count":36,"title":["Evaluation of Lassa virus vaccine immunogenicity in a CBA\/J-ML29 mouse model"],"prefix":"10.1016","volume":"30","author":[{"given":"Marco A.","family":"Goicochea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Salvato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor S.","family":"Lukashevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.12.134_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-3-642-56029-3_4","article-title":"Lassa fever","volume":"262","author":"McCormick","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0010","series-title":"New generation vaccines","article-title":"Vaccines against Lassa fever","author":"Salvato","year":"2009"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.134_bib0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1586\/eri.10.142","article-title":"Pathogenesis of arenavirus hemorrhagic fevers","volume":"9","author":"Moraz","year":"2011","journal-title":"Expert Rev Anti-infect Ther"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.05616-11","article-title":"Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP","author":"Droniou-Bonzom","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0025","series-title":"Virus taxonomy, IXth report of the ICTV","first-page":"715","article-title":"Arenaviridae","author":"Salvato","year":"2005"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-642-56055-2_6","article-title":"Biology and pathogenesis of lymphocytic choriomeningitis virus infection","volume":"263","author":"Oldstone","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.12.134_bib0035","first-page":"148","article-title":"Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses","volume":"162","author":"Grant-Klein","year":"2011","journal-title":"Antivir Res"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.134_bib0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2007.11.003","article-title":"New opportunities for field research on the pathogenesis and treatment of Lassa fever","volume":"78","author":"Khan","year":"2008","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.134_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000388","article-title":"Risk maps of Lassa fever in West Africa","volume":"3","author":"Fichet-Calvet","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0050","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.05691-11","article-title":"Molecular determinants of Arenavirus Z protein homo-oligomerization and L polymerase binding","author":"Loureiro","year":"2011","journal-title":"J Virol"},{"issue":"November (7426)","key":"10.1016\/j.vaccine.2011.12.134_bib0055","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","article-title":"Lassa fever: epidemiology, clinical features, and social consequences","volume":"327","author":"Richmond","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0060","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3201\/eid1510.090211","article-title":"Nosocomial outbreak of novel arenavirus infection, southern Africa","volume":"15","author":"Paweska","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.134_bib0065","doi-asserted-by":"crossref","first-page":"e1000455","DOI":"10.1371\/journal.ppat.1000455","article-title":"Genetic detection and characterization of lujo virus, a new hemorrhagic fever-associated arenavirus from Southern Africa","volume":"4","author":"Briese","year":"2009","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.vaccine.2011.12.134_bib0070","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3201\/eid1710.10452","article-title":"Novel arenavirus Zambia","volume":"17","author":"Ishii","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2011.12.134_bib0075","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1990.03450160063030","article-title":"Acute sensorineural deafness in Lassa fever","volume":"264","author":"Cummins","year":"1990","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.134_bib0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/019459989210600303","article-title":"Audiometric comparison of Lassa fever hearing loss and idiopathic sudden hearing loss: evidence for viral cause","volume":"106","author":"Liao","year":"1992","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.134_bib0085","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3201\/eid1205.050052","article-title":"Historical Lassa fevers reports and 30-year clinical update","volume":"12","author":"Macher","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.12.134_bib0090","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/AAC.00650-11","article-title":"Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors","volume":"55","author":"Neuman","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"18","key":"10.1016\/j.vaccine.2011.12.134_bib0095","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2011.12.134_bib0100","doi-asserted-by":"crossref","first-page":"11058","DOI":"10.1128\/JVI.05304-11","article-title":"Junin virus infects mouse cells and induces innate immune responses","volume":"85","author":"Cuevas","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/978-3-642-71726-0_2","article-title":"Experimental studies of arenaviral hemorrhagic fevers","volume":"134","author":"Peters","year":"1987","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2007.10.002","article-title":"Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses","volume":"78","author":"Gowen","year":"2008","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0115","series-title":"Molecular pathogenesis of hemorrhagic fever viruses","first-page":"101","article-title":"Pathogenesis of Lassa virus infection in experimental animals","author":"Lukashevich","year":"2010"},{"issue":"April (12)","key":"10.1016\/j.vaccine.2011.12.134_bib0120","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1128\/JVI.02876-06","article-title":"Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues","volume":"81","author":"Carrion","year":"2007","journal-title":"J Virol"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.12.134_bib0125","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1128\/JVI.01948-08","article-title":"Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys","volume":"83","author":"Baize","year":"2009","journal-title":"J Virol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.12.134_bib0130","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4269\/ajtmh.2006.74.1096","article-title":"Clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with pirital virus (arenaviridae): a rodent model of Lassa fever","volume":"74","author":"Sbrana","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.134_bib0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2011.07.015","article-title":"Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever","volume":"92","author":"Zapata","year":"2011","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.134_bib0140","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0042-6822(92)90514-P","article-title":"Generation of reassortants between African arenaviruses","volume":"188","author":"Lukashevich","year":"1992","journal-title":"Virology"},{"issue":"22","key":"10.1016\/j.vaccine.2011.12.134_bib0145","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","article-title":"A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses","volume":"79","author":"Lukashevich","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0150","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1016\/j.vaccine.2008.07.057","article-title":"Safety, immunogenicity, and efficacy of the ML29 vaccine for Lassa fever in small non-human primates","volume":"26","author":"Lukashevich","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0155","series-title":"Molecular pathogenesis of hemorrhagic fever viruses","article-title":"A live reassortant vaccine for Lassa fever","author":"Lukashevich","year":"2010"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.134_bib0160","first-page":"207","article-title":"Lassa virus lethality for inbred mice","volume":"65","author":"Lukashevich","year":"1985","journal-title":"Ann Soc Belg Med Trop"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2011.12.134_bib0165","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"Pushko","year":"2001","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.12.134_bib0170","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00705-004-0385-9","article-title":"LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration","volume":"149","author":"Lukashevich","year":"2004","journal-title":"Arch Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.134_bib0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jmv.1890400308","article-title":"Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen","volume":"40","author":"Lukashevich","year":"1993","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.12.134_bib0180","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.vaccine.2010.11.079","article-title":"Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs","volume":"29","author":"Jiang","year":"2011","journal-title":"Vaccine"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.12.134_bib0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4049\/jimmunol.171.1.27","article-title":"Cutting edge: rapid in vivo killing by memory CD8 T cells","volume":"171","author":"Barber","year":"2003","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.12.134_bib0190","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1128\/JVI.67.6.3497-3506.1993","article-title":"Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus","volume":"67","author":"La Posta","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0195","first-page":"598","article-title":"Lassa and Mozambique viruses: cross protection in experiments on mice and action of immunosuppressants on experimental infections","volume":"34","author":"Barkar","year":"1989","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0200","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0166-3542(85)90044-0","article-title":"Exquisite specificity of adoptive immunization in arenavirus-infected mice","volume":"5","author":"McIntyre","year":"1985","journal-title":"Antivir Res"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.134_bib0205","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever, effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N Engl J Med"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2011.12.134_bib0210","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.1128\/JVI.00896-06","article-title":"Identification of protective Lassa virus epitopes that are restricted by HLA-A2","volume":"80","author":"Botten","year":"2006","journal-title":"J Virol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.12.134_bib0215","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/CDLI.12.10.1223-1230.2005","article-title":"Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2. 1 Transgenic Mice","volume":"12","author":"Boesen","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.134_bib0220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virol.2003.12.013","article-title":"Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones","volume":"321","author":"Meulen","year":"2004","journal-title":"Virology"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2011.12.134_bib0225","doi-asserted-by":"crossref","first-page":"11770","DOI":"10.1128\/JVI.05477-11","article-title":"Human CD8+ and CD4+ T cell memory to lymphocytic choriomeningitis virus infection","volume":"85","author":"Kotturi","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.12.134_bib0230","series-title":"Proceedings of the National Academy of Sciences","article-title":"Crystal structure of the Lassa virus nucleoprotein\u2013RNA complex reveals a gating mechanism for RNA binding","author":"Hastie","year":"2011"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.134_bib0235","doi-asserted-by":"crossref","first-page":"e1000836","DOI":"10.1371\/journal.ppat.1000836","article-title":"T cell-dependence of Lassa fever pathogenesis","volume":"6","author":"Flatz","year":"2010","journal-title":"PLoS Pathogen"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.134_bib0240","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/eji.200425730","article-title":"MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection","volume":"35","author":"Zhou","year":"2005","journal-title":"Eur J Immunol"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2011.12.134_bib0245","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1128\/JVI.00155-10","article-title":"Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus","volume":"84","author":"Zhou","year":"2010","journal-title":"J Virol"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2011.12.134_bib0250","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1128\/JVI.01770-08","article-title":"MyD88 intrinsically regulates CD4 T-cell responses","volume":"83","author":"Zhou","year":"2009","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.12.134_bib0255","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/JVI.01640-07","article-title":"Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88","volume":"82","author":"Jung","year":"2008","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.12.134_bib0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2007.11.018","article-title":"Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88\/Mal-dependent inflammatory responses","volume":"194","author":"Zhou","year":"2008","journal-title":"J Neuroimmunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T14:46:45Z","timestamp":1593528405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11020950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0264410X11020950"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.134","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}